nodes	percent_of_prediction	percent_of_DWPC	metapath
Danazol—CCL2—Alzheimer's disease	0.454	0.722	CbGaD
Danazol—ESR1—Alzheimer's disease	0.175	0.278	CbGaD
Danazol—CYP3A4—Rivastigmine—Alzheimer's disease	0.0393	0.432	CbGbCtD
Danazol—CYP3A4—Donepezil—Alzheimer's disease	0.0315	0.345	CbGbCtD
Danazol—CYP3A4—Galantamine—Alzheimer's disease	0.0203	0.223	CbGbCtD
Danazol—Hypertrophy—Donepezil—Alzheimer's disease	0.0113	0.0863	CcSEcCtD
Danazol—CCL2—blood vessel—Alzheimer's disease	0.00449	0.105	CbGeAlD
Danazol—Polycythaemia—Memantine—Alzheimer's disease	0.00443	0.0338	CcSEcCtD
Danazol—Carpal tunnel syndrome—Memantine—Alzheimer's disease	0.00443	0.0338	CcSEcCtD
Danazol—CCL2—embryo—Alzheimer's disease	0.00268	0.0626	CbGeAlD
Danazol—Epilepsy—Rivastigmine—Alzheimer's disease	0.00249	0.019	CcSEcCtD
Danazol—CCL2—forebrain—Alzheimer's disease	0.00237	0.0553	CbGeAlD
Danazol—PGR—blood vessel—Alzheimer's disease	0.00236	0.0551	CbGeAlD
Danazol—Epigastric pain—Donepezil—Alzheimer's disease	0.0022	0.0168	CcSEcCtD
Danazol—CCL2—telencephalon—Alzheimer's disease	0.00218	0.0509	CbGeAlD
Danazol—ESR1—blood vessel—Alzheimer's disease	0.00184	0.0431	CbGeAlD
Danazol—Hirsutism—Donepezil—Alzheimer's disease	0.00183	0.014	CcSEcCtD
Danazol—GNRHR—nervous system—Alzheimer's disease	0.00165	0.0385	CbGeAlD
Danazol—GNRHR—central nervous system—Alzheimer's disease	0.00159	0.0371	CbGeAlD
Danazol—GNRHR—cerebellum—Alzheimer's disease	0.00155	0.0362	CbGeAlD
Danazol—Throat sore—Donepezil—Alzheimer's disease	0.00148	0.0113	CcSEcCtD
Danazol—Oropharyngeal discomfort—Donepezil—Alzheimer's disease	0.00146	0.0112	CcSEcCtD
Danazol—Cataract—Galantamine—Alzheimer's disease	0.00144	0.011	CcSEcCtD
Danazol—Seborrhoeic dermatitis—Rivastigmine—Alzheimer's disease	0.00139	0.0106	CcSEcCtD
Danazol—Thrombosis—Rivastigmine—Alzheimer's disease	0.00134	0.0102	CcSEcCtD
Danazol—CCL2—nervous system—Alzheimer's disease	0.00129	0.03	CbGeAlD
Danazol—GNRHR—brain—Alzheimer's disease	0.00126	0.0294	CbGeAlD
Danazol—CCL2—central nervous system—Alzheimer's disease	0.00124	0.0289	CbGeAlD
Danazol—CCL2—cerebellum—Alzheimer's disease	0.00121	0.0283	CbGeAlD
Danazol—Oropharyngeal pain—Donepezil—Alzheimer's disease	0.00117	0.00894	CcSEcCtD
Danazol—Dysphonia—Rivastigmine—Alzheimer's disease	0.00115	0.00878	CcSEcCtD
Danazol—Leukocytosis—Donepezil—Alzheimer's disease	0.00113	0.00865	CcSEcCtD
Danazol—Gastroenteritis—Galantamine—Alzheimer's disease	0.00112	0.00859	CcSEcCtD
Danazol—CYP19A1—forebrain—Alzheimer's disease	0.00112	0.0262	CbGeAlD
Danazol—Cataract—Donepezil—Alzheimer's disease	0.00112	0.00854	CcSEcCtD
Danazol—ESR1—embryo—Alzheimer's disease	0.0011	0.0257	CbGeAlD
Danazol—Leukocytosis—Memantine—Alzheimer's disease	0.00103	0.00786	CcSEcCtD
Danazol—Cataract—Memantine—Alzheimer's disease	0.00101	0.00776	CcSEcCtD
Danazol—Leukocytosis—Rivastigmine—Alzheimer's disease	0.00101	0.00769	CcSEcCtD
Danazol—Cataract—Rivastigmine—Alzheimer's disease	0.000993	0.00759	CcSEcCtD
Danazol—AR—forebrain—Alzheimer's disease	0.000991	0.0232	CbGeAlD
Danazol—CCL2—brain—Alzheimer's disease	0.000982	0.023	CbGeAlD
Danazol—ESR1—forebrain—Alzheimer's disease	0.000973	0.0227	CbGeAlD
Danazol—AR—telencephalon—Alzheimer's disease	0.000912	0.0213	CbGeAlD
Danazol—Abdominal pain upper—Galantamine—Alzheimer's disease	0.00091	0.00696	CcSEcCtD
Danazol—Fluid retention—Rivastigmine—Alzheimer's disease	0.000897	0.00686	CcSEcCtD
Danazol—ESR1—telencephalon—Alzheimer's disease	0.000895	0.0209	CbGeAlD
Danazol—Gastroenteritis—Donepezil—Alzheimer's disease	0.000871	0.00666	CcSEcCtD
Danazol—Sleep disorder—Memantine—Alzheimer's disease	0.00081	0.00619	CcSEcCtD
Danazol—Hepatic function abnormal—Memantine—Alzheimer's disease	0.000802	0.00613	CcSEcCtD
Danazol—Sleep disorder—Rivastigmine—Alzheimer's disease	0.000793	0.00606	CcSEcCtD
Danazol—Gastroenteritis—Memantine—Alzheimer's disease	0.000791	0.00605	CcSEcCtD
Danazol—Gastroenteritis—Rivastigmine—Alzheimer's disease	0.000774	0.00592	CcSEcCtD
Danazol—Affect lability—Donepezil—Alzheimer's disease	0.00076	0.00581	CcSEcCtD
Danazol—Irritability—Donepezil—Alzheimer's disease	0.000737	0.00563	CcSEcCtD
Danazol—Haematuria—Galantamine—Alzheimer's disease	0.000732	0.0056	CcSEcCtD
Danazol—Mood swings—Donepezil—Alzheimer's disease	0.000732	0.00559	CcSEcCtD
Danazol—SHBG—central nervous system—Alzheimer's disease	0.000722	0.0169	CbGeAlD
Danazol—SHBG—cerebellum—Alzheimer's disease	0.000706	0.0165	CbGeAlD
Danazol—Abdominal pain upper—Donepezil—Alzheimer's disease	0.000705	0.00539	CcSEcCtD
Danazol—Cramp muscle—Donepezil—Alzheimer's disease	0.000696	0.00532	CcSEcCtD
Danazol—Haemoglobin—Galantamine—Alzheimer's disease	0.000693	0.0053	CcSEcCtD
Danazol—Affect lability—Memantine—Alzheimer's disease	0.00069	0.00528	CcSEcCtD
Danazol—Haemorrhage—Galantamine—Alzheimer's disease	0.000689	0.00527	CcSEcCtD
Danazol—PGR—nervous system—Alzheimer's disease	0.000675	0.0158	CbGeAlD
Danazol—Migraine—Rivastigmine—Alzheimer's disease	0.000675	0.00516	CcSEcCtD
Danazol—Affect lability—Rivastigmine—Alzheimer's disease	0.000675	0.00516	CcSEcCtD
Danazol—Irritability—Memantine—Alzheimer's disease	0.000669	0.00512	CcSEcCtD
Danazol—Visual impairment—Galantamine—Alzheimer's disease	0.000664	0.00508	CcSEcCtD
Danazol—Mood swings—Memantine—Alzheimer's disease	0.000664	0.00508	CcSEcCtD
Danazol—Eosinophilia—Donepezil—Alzheimer's disease	0.000661	0.00505	CcSEcCtD
Danazol—Pancreatitis—Donepezil—Alzheimer's disease	0.000655	0.005	CcSEcCtD
Danazol—PGR—central nervous system—Alzheimer's disease	0.00065	0.0152	CbGeAlD
Danazol—Mood swings—Rivastigmine—Alzheimer's disease	0.00065	0.00497	CcSEcCtD
Danazol—Flushing—Galantamine—Alzheimer's disease	0.00064	0.00489	CcSEcCtD
Danazol—PGR—cerebellum—Alzheimer's disease	0.000636	0.0149	CbGeAlD
Danazol—Abdominal pain upper—Rivastigmine—Alzheimer's disease	0.000627	0.00479	CcSEcCtD
Danazol—Cramp muscle—Rivastigmine—Alzheimer's disease	0.000618	0.00472	CcSEcCtD
Danazol—CYP19A1—nervous system—Alzheimer's disease	0.000608	0.0142	CbGeAlD
Danazol—Weight increased—Donepezil—Alzheimer's disease	0.000608	0.00464	CcSEcCtD
Danazol—Quinestrol—ESR1—Alzheimer's disease	0.000605	0.185	CrCbGaD
Danazol—Pancreatitis—Memantine—Alzheimer's disease	0.000594	0.00454	CcSEcCtD
Danazol—Tension—Galantamine—Alzheimer's disease	0.000589	0.0045	CcSEcCtD
Danazol—Acute coronary syndrome—Donepezil—Alzheimer's disease	0.000587	0.00448	CcSEcCtD
Danazol—CYP19A1—central nervous system—Alzheimer's disease	0.000585	0.0137	CbGeAlD
Danazol—Myocardial infarction—Donepezil—Alzheimer's disease	0.000583	0.00446	CcSEcCtD
Danazol—Nervousness—Galantamine—Alzheimer's disease	0.000583	0.00446	CcSEcCtD
Danazol—Pancreatitis—Rivastigmine—Alzheimer's disease	0.000581	0.00444	CcSEcCtD
Danazol—Back pain—Galantamine—Alzheimer's disease	0.000581	0.00444	CcSEcCtD
Danazol—Jaundice—Donepezil—Alzheimer's disease	0.00058	0.00443	CcSEcCtD
Danazol—Muscle spasms—Galantamine—Alzheimer's disease	0.000577	0.00441	CcSEcCtD
Danazol—SHBG—brain—Alzheimer's disease	0.000573	0.0134	CbGeAlD
Danazol—Sweating—Donepezil—Alzheimer's disease	0.000571	0.00436	CcSEcCtD
Danazol—Haematuria—Donepezil—Alzheimer's disease	0.000568	0.00434	CcSEcCtD
Danazol—Vision blurred—Galantamine—Alzheimer's disease	0.000566	0.00432	CcSEcCtD
Danazol—Tremor—Galantamine—Alzheimer's disease	0.000562	0.0043	CcSEcCtD
Danazol—Weight increased—Memantine—Alzheimer's disease	0.000552	0.00422	CcSEcCtD
Danazol—Photosensitivity reaction—Rivastigmine—Alzheimer's disease	0.000541	0.00414	CcSEcCtD
Danazol—Weight increased—Rivastigmine—Alzheimer's disease	0.00054	0.00412	CcSEcCtD
Danazol—Vertigo—Galantamine—Alzheimer's disease	0.000539	0.00412	CcSEcCtD
Danazol—Syncope—Galantamine—Alzheimer's disease	0.000538	0.00411	CcSEcCtD
Danazol—AR—nervous system—Alzheimer's disease	0.000538	0.0126	CbGeAlD
Danazol—Haemoglobin—Donepezil—Alzheimer's disease	0.000537	0.0041	CcSEcCtD
Danazol—Stevens-Johnson syndrome—Memantine—Alzheimer's disease	0.000536	0.00409	CcSEcCtD
Danazol—Haemorrhage—Donepezil—Alzheimer's disease	0.000534	0.00408	CcSEcCtD
Danazol—Acute coronary syndrome—Memantine—Alzheimer's disease	0.000533	0.00407	CcSEcCtD
Danazol—Palpitations—Galantamine—Alzheimer's disease	0.00053	0.00405	CcSEcCtD
Danazol—Myocardial infarction—Memantine—Alzheimer's disease	0.00053	0.00405	CcSEcCtD
Danazol—ESR1—nervous system—Alzheimer's disease	0.000528	0.0123	CbGeAlD
Danazol—Loss of consciousness—Galantamine—Alzheimer's disease	0.000528	0.00403	CcSEcCtD
Danazol—Stevens-Johnson syndrome—Rivastigmine—Alzheimer's disease	0.000524	0.00401	CcSEcCtD
Danazol—Acute coronary syndrome—Rivastigmine—Alzheimer's disease	0.000521	0.00398	CcSEcCtD
Danazol—Convulsion—Galantamine—Alzheimer's disease	0.00052	0.00397	CcSEcCtD
Danazol—Myocardial infarction—Rivastigmine—Alzheimer's disease	0.000518	0.00396	CcSEcCtD
Danazol—Hypertension—Galantamine—Alzheimer's disease	0.000518	0.00396	CcSEcCtD
Danazol—AR—central nervous system—Alzheimer's disease	0.000518	0.0121	CbGeAlD
Danazol—PGR—brain—Alzheimer's disease	0.000516	0.0121	CbGeAlD
Danazol—Haematuria—Memantine—Alzheimer's disease	0.000515	0.00394	CcSEcCtD
Danazol—Visual impairment—Donepezil—Alzheimer's disease	0.000515	0.00394	CcSEcCtD
Danazol—Arthralgia—Galantamine—Alzheimer's disease	0.000511	0.00391	CcSEcCtD
Danazol—Anxiety—Galantamine—Alzheimer's disease	0.000509	0.00389	CcSEcCtD
Danazol—ESR1—central nervous system—Alzheimer's disease	0.000509	0.0119	CbGeAlD
Danazol—Sweating—Rivastigmine—Alzheimer's disease	0.000507	0.00387	CcSEcCtD
Danazol—Haematuria—Rivastigmine—Alzheimer's disease	0.000504	0.00385	CcSEcCtD
Danazol—ESR1—cerebellum—Alzheimer's disease	0.000497	0.0116	CbGeAlD
Danazol—Haemoglobin—Memantine—Alzheimer's disease	0.000488	0.00373	CcSEcCtD
Danazol—Haemorrhage—Memantine—Alzheimer's disease	0.000485	0.00371	CcSEcCtD
Danazol—Shock—Galantamine—Alzheimer's disease	0.000482	0.00368	CcSEcCtD
Danazol—Thrombocytopenia—Galantamine—Alzheimer's disease	0.00048	0.00367	CcSEcCtD
Danazol—Chills—Donepezil—Alzheimer's disease	0.000479	0.00366	CcSEcCtD
Danazol—Tachycardia—Galantamine—Alzheimer's disease	0.000478	0.00365	CcSEcCtD
Danazol—Haemoglobin—Rivastigmine—Alzheimer's disease	0.000477	0.00365	CcSEcCtD
Danazol—Haemorrhage—Rivastigmine—Alzheimer's disease	0.000475	0.00363	CcSEcCtD
Danazol—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000474	0.00362	CcSEcCtD
Danazol—Alopecia—Donepezil—Alzheimer's disease	0.000472	0.00361	CcSEcCtD
Danazol—Visual impairment—Memantine—Alzheimer's disease	0.000468	0.00357	CcSEcCtD
Danazol—CYP19A1—brain—Alzheimer's disease	0.000465	0.0109	CbGeAlD
Danazol—Mestranol—ESR1—Alzheimer's disease	0.000459	0.141	CrCbGaD
Danazol—Trilostane—ESR1—Alzheimer's disease	0.000459	0.141	CrCbGaD
Danazol—Erythema multiforme—Memantine—Alzheimer's disease	0.000459	0.00351	CcSEcCtD
Danazol—Visual impairment—Rivastigmine—Alzheimer's disease	0.000457	0.0035	CcSEcCtD
Danazol—Tension—Donepezil—Alzheimer's disease	0.000456	0.00349	CcSEcCtD
Danazol—Desogestrel—ESR1—Alzheimer's disease	0.000453	0.139	CrCbGaD
Danazol—Nervousness—Donepezil—Alzheimer's disease	0.000452	0.00345	CcSEcCtD
Danazol—Flushing—Memantine—Alzheimer's disease	0.00045	0.00344	CcSEcCtD
Danazol—Back pain—Donepezil—Alzheimer's disease	0.00045	0.00344	CcSEcCtD
Danazol—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.000449	0.00343	CcSEcCtD
Danazol—Muscle spasms—Donepezil—Alzheimer's disease	0.000447	0.00342	CcSEcCtD
Danazol—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000446	0.00341	CcSEcCtD
Danazol—Flushing—Rivastigmine—Alzheimer's disease	0.00044	0.00337	CcSEcCtD
Danazol—Paraesthesia—Galantamine—Alzheimer's disease	0.00044	0.00336	CcSEcCtD
Danazol—Vision blurred—Donepezil—Alzheimer's disease	0.000438	0.00335	CcSEcCtD
Danazol—Tremor—Donepezil—Alzheimer's disease	0.000436	0.00333	CcSEcCtD
Danazol—Chills—Memantine—Alzheimer's disease	0.000435	0.00333	CcSEcCtD
Danazol—Dyspepsia—Galantamine—Alzheimer's disease	0.000431	0.0033	CcSEcCtD
Danazol—Alopecia—Memantine—Alzheimer's disease	0.000429	0.00328	CcSEcCtD
Danazol—Chills—Rivastigmine—Alzheimer's disease	0.000426	0.00325	CcSEcCtD
Danazol—Fatigue—Galantamine—Alzheimer's disease	0.000422	0.00323	CcSEcCtD
Danazol—Alopecia—Rivastigmine—Alzheimer's disease	0.000419	0.00321	CcSEcCtD
Danazol—Constipation—Galantamine—Alzheimer's disease	0.000419	0.0032	CcSEcCtD
Danazol—Vertigo—Donepezil—Alzheimer's disease	0.000418	0.00319	CcSEcCtD
Danazol—Syncope—Donepezil—Alzheimer's disease	0.000417	0.00319	CcSEcCtD
Danazol—Tension—Memantine—Alzheimer's disease	0.000414	0.00317	CcSEcCtD
Danazol—AR—brain—Alzheimer's disease	0.000411	0.00962	CbGeAlD
Danazol—Nervousness—Memantine—Alzheimer's disease	0.00041	0.00314	CcSEcCtD
Danazol—Loss of consciousness—Donepezil—Alzheimer's disease	0.000409	0.00312	CcSEcCtD
Danazol—Back pain—Memantine—Alzheimer's disease	0.000409	0.00312	CcSEcCtD
Danazol—Tension—Rivastigmine—Alzheimer's disease	0.000405	0.0031	CcSEcCtD
Danazol—ESR1—brain—Alzheimer's disease	0.000404	0.00944	CbGeAlD
Danazol—Convulsion—Donepezil—Alzheimer's disease	0.000403	0.00308	CcSEcCtD
Danazol—Hypertension—Donepezil—Alzheimer's disease	0.000402	0.00307	CcSEcCtD
Danazol—Nervousness—Rivastigmine—Alzheimer's disease	0.000401	0.00307	CcSEcCtD
Danazol—Back pain—Rivastigmine—Alzheimer's disease	0.0004	0.00305	CcSEcCtD
Danazol—Vision blurred—Memantine—Alzheimer's disease	0.000398	0.00304	CcSEcCtD
Danazol—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000397	0.00304	CcSEcCtD
Danazol—Arthralgia—Donepezil—Alzheimer's disease	0.000396	0.00303	CcSEcCtD
Danazol—Tremor—Memantine—Alzheimer's disease	0.000396	0.00302	CcSEcCtD
Danazol—Anxiety—Donepezil—Alzheimer's disease	0.000395	0.00302	CcSEcCtD
Danazol—Vision blurred—Rivastigmine—Alzheimer's disease	0.000389	0.00298	CcSEcCtD
Danazol—Body temperature increased—Galantamine—Alzheimer's disease	0.000387	0.00296	CcSEcCtD
Danazol—Tremor—Rivastigmine—Alzheimer's disease	0.000387	0.00296	CcSEcCtD
Danazol—Oedema—Donepezil—Alzheimer's disease	0.00038	0.0029	CcSEcCtD
Danazol—Vertigo—Memantine—Alzheimer's disease	0.000379	0.0029	CcSEcCtD
Danazol—Syncope—Memantine—Alzheimer's disease	0.000379	0.00289	CcSEcCtD
Danazol—Leukopenia—Memantine—Alzheimer's disease	0.000378	0.00289	CcSEcCtD
Danazol—Shock—Donepezil—Alzheimer's disease	0.000373	0.00285	CcSEcCtD
Danazol—Palpitations—Memantine—Alzheimer's disease	0.000373	0.00285	CcSEcCtD
Danazol—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000372	0.00284	CcSEcCtD
Danazol—Vertigo—Rivastigmine—Alzheimer's disease	0.000371	0.00284	CcSEcCtD
Danazol—Loss of consciousness—Memantine—Alzheimer's disease	0.000371	0.00284	CcSEcCtD
Danazol—Syncope—Rivastigmine—Alzheimer's disease	0.000371	0.00283	CcSEcCtD
Danazol—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000367	0.0028	CcSEcCtD
Danazol—Etonogestrel—ESR1—Alzheimer's disease	0.000367	0.112	CrCbGaD
Danazol—Convulsion—Memantine—Alzheimer's disease	0.000366	0.0028	CcSEcCtD
Danazol—Palpitations—Rivastigmine—Alzheimer's disease	0.000365	0.00279	CcSEcCtD
Danazol—Hypertension—Memantine—Alzheimer's disease	0.000365	0.00279	CcSEcCtD
Danazol—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000363	0.00278	CcSEcCtD
Danazol—Arthralgia—Memantine—Alzheimer's disease	0.00036	0.00275	CcSEcCtD
Danazol—Anxiety—Memantine—Alzheimer's disease	0.000358	0.00274	CcSEcCtD
Danazol—Convulsion—Rivastigmine—Alzheimer's disease	0.000358	0.00274	CcSEcCtD
Danazol—Hypertension—Rivastigmine—Alzheimer's disease	0.000357	0.00273	CcSEcCtD
Danazol—Arthralgia—Rivastigmine—Alzheimer's disease	0.000352	0.00269	CcSEcCtD
Danazol—Asthenia—Galantamine—Alzheimer's disease	0.000351	0.00269	CcSEcCtD
Danazol—Anxiety—Rivastigmine—Alzheimer's disease	0.000351	0.00268	CcSEcCtD
Danazol—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000346	0.00264	CcSEcCtD
Danazol—Oedema—Memantine—Alzheimer's disease	0.000345	0.00263	CcSEcCtD
Danazol—Paraesthesia—Donepezil—Alzheimer's disease	0.000341	0.00261	CcSEcCtD
Danazol—Shock—Memantine—Alzheimer's disease	0.000339	0.00259	CcSEcCtD
Danazol—Thrombocytopenia—Memantine—Alzheimer's disease	0.000337	0.00258	CcSEcCtD
Danazol—Oedema—Rivastigmine—Alzheimer's disease	0.000337	0.00258	CcSEcCtD
Danazol—Tachycardia—Memantine—Alzheimer's disease	0.000336	0.00257	CcSEcCtD
Danazol—Dyspepsia—Donepezil—Alzheimer's disease	0.000334	0.00255	CcSEcCtD
Danazol—Hyperhidrosis—Memantine—Alzheimer's disease	0.000333	0.00255	CcSEcCtD
Danazol—Shock—Rivastigmine—Alzheimer's disease	0.000332	0.00254	CcSEcCtD
Danazol—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.00033	0.00252	CcSEcCtD
Danazol—Tachycardia—Rivastigmine—Alzheimer's disease	0.000329	0.00252	CcSEcCtD
Danazol—Fatigue—Donepezil—Alzheimer's disease	0.000327	0.0025	CcSEcCtD
Danazol—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000326	0.00249	CcSEcCtD
Danazol—Constipation—Donepezil—Alzheimer's disease	0.000325	0.00248	CcSEcCtD
Danazol—Dizziness—Galantamine—Alzheimer's disease	0.000324	0.00248	CcSEcCtD
Danazol—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000314	0.0024	CcSEcCtD
Danazol—Vomiting—Galantamine—Alzheimer's disease	0.000311	0.00238	CcSEcCtD
Danazol—Paraesthesia—Memantine—Alzheimer's disease	0.00031	0.00237	CcSEcCtD
Danazol—Rash—Galantamine—Alzheimer's disease	0.000309	0.00236	CcSEcCtD
Danazol—Dermatitis—Galantamine—Alzheimer's disease	0.000309	0.00236	CcSEcCtD
Danazol—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000307	0.00235	CcSEcCtD
Danazol—Headache—Galantamine—Alzheimer's disease	0.000307	0.00235	CcSEcCtD
Danazol—Dyspepsia—Memantine—Alzheimer's disease	0.000303	0.00232	CcSEcCtD
Danazol—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000303	0.00231	CcSEcCtD
Danazol—Urticaria—Donepezil—Alzheimer's disease	0.000302	0.0023	CcSEcCtD
Danazol—Body temperature increased—Donepezil—Alzheimer's disease	0.0003	0.00229	CcSEcCtD
Danazol—Fatigue—Memantine—Alzheimer's disease	0.000297	0.00227	CcSEcCtD
Danazol—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000297	0.00227	CcSEcCtD
Danazol—CYP3A4—nervous system—Alzheimer's disease	0.000295	0.00689	CbGeAlD
Danazol—Constipation—Memantine—Alzheimer's disease	0.000295	0.00225	CcSEcCtD
Danazol—Nausea—Galantamine—Alzheimer's disease	0.000291	0.00222	CcSEcCtD
Danazol—Fatigue—Rivastigmine—Alzheimer's disease	0.000291	0.00222	CcSEcCtD
Danazol—Constipation—Rivastigmine—Alzheimer's disease	0.000288	0.0022	CcSEcCtD
Danazol—CYP3A4—central nervous system—Alzheimer's disease	0.000284	0.00663	CbGeAlD
Danazol—Urticaria—Memantine—Alzheimer's disease	0.000274	0.00209	CcSEcCtD
Danazol—Body temperature increased—Memantine—Alzheimer's disease	0.000272	0.00208	CcSEcCtD
Danazol—Asthenia—Donepezil—Alzheimer's disease	0.000272	0.00208	CcSEcCtD
Danazol—Pruritus—Donepezil—Alzheimer's disease	0.000269	0.00205	CcSEcCtD
Danazol—Urticaria—Rivastigmine—Alzheimer's disease	0.000268	0.00205	CcSEcCtD
Danazol—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000267	0.00204	CcSEcCtD
Danazol—Levonorgestrel—ESR1—Alzheimer's disease	0.00026	0.0795	CrCbGaD
Danazol—Dizziness—Donepezil—Alzheimer's disease	0.000251	0.00192	CcSEcCtD
Danazol—Fluoxymesterone—ESR1—Alzheimer's disease	0.000247	0.0758	CrCbGaD
Danazol—Asthenia—Memantine—Alzheimer's disease	0.000247	0.00189	CcSEcCtD
Danazol—Pruritus—Memantine—Alzheimer's disease	0.000244	0.00186	CcSEcCtD
Danazol—Asthenia—Rivastigmine—Alzheimer's disease	0.000242	0.00185	CcSEcCtD
Danazol—Vomiting—Donepezil—Alzheimer's disease	0.000241	0.00184	CcSEcCtD
Danazol—Rash—Donepezil—Alzheimer's disease	0.000239	0.00183	CcSEcCtD
Danazol—Dermatitis—Donepezil—Alzheimer's disease	0.000239	0.00183	CcSEcCtD
Danazol—Pruritus—Rivastigmine—Alzheimer's disease	0.000239	0.00182	CcSEcCtD
Danazol—Headache—Donepezil—Alzheimer's disease	0.000238	0.00182	CcSEcCtD
Danazol—Dizziness—Memantine—Alzheimer's disease	0.000228	0.00174	CcSEcCtD
Danazol—Nausea—Donepezil—Alzheimer's disease	0.000225	0.00172	CcSEcCtD
Danazol—Dizziness—Rivastigmine—Alzheimer's disease	0.000223	0.0017	CcSEcCtD
Danazol—Vomiting—Memantine—Alzheimer's disease	0.000219	0.00167	CcSEcCtD
Danazol—Ethinyl Estradiol—ESR1—Alzheimer's disease	0.000219	0.067	CrCbGaD
Danazol—Rash—Memantine—Alzheimer's disease	0.000217	0.00166	CcSEcCtD
Danazol—Dermatitis—Memantine—Alzheimer's disease	0.000217	0.00166	CcSEcCtD
Danazol—Headache—Memantine—Alzheimer's disease	0.000216	0.00165	CcSEcCtD
Danazol—Vomiting—Rivastigmine—Alzheimer's disease	0.000214	0.00164	CcSEcCtD
Danazol—Rash—Rivastigmine—Alzheimer's disease	0.000213	0.00162	CcSEcCtD
Danazol—Dermatitis—Rivastigmine—Alzheimer's disease	0.000212	0.00162	CcSEcCtD
Danazol—Headache—Rivastigmine—Alzheimer's disease	0.000211	0.00161	CcSEcCtD
Danazol—Nausea—Memantine—Alzheimer's disease	0.000205	0.00156	CcSEcCtD
Danazol—Nausea—Rivastigmine—Alzheimer's disease	0.0002	0.00153	CcSEcCtD
Danazol—Progesterone—ESR1—Alzheimer's disease	0.000123	0.0375	CrCbGaD
Danazol—Progesterone—CYP2D6—Alzheimer's disease	7.29e-05	0.0223	CrCbGaD
Danazol—CCL2—Signaling Pathways—IGF1R—Alzheimer's disease	2.48e-05	0.000241	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	2.47e-05	0.00024	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—S100B—Alzheimer's disease	2.46e-05	0.000239	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PSEN2—Alzheimer's disease	2.44e-05	0.000237	CbGpPWpGaD
Danazol—AR—Generic Transcription Pathway—PPARG—Alzheimer's disease	2.44e-05	0.000236	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PYY—Alzheimer's disease	2.42e-05	0.000235	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	2.41e-05	0.000234	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—TP53—Alzheimer's disease	2.38e-05	0.000231	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—LPL—Alzheimer's disease	2.38e-05	0.000231	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—MEF2C—Alzheimer's disease	2.36e-05	0.000229	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—IGF2—Alzheimer's disease	2.35e-05	0.000228	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	2.34e-05	0.000227	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—AKT1—Alzheimer's disease	2.34e-05	0.000227	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—PRKCG—Alzheimer's disease	2.31e-05	0.000224	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	2.3e-05	0.000223	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—IGF1R—Alzheimer's disease	2.27e-05	0.00022	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—NGF—Alzheimer's disease	2.25e-05	0.000218	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—NPY—Alzheimer's disease	2.25e-05	0.000218	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—IAPP—Alzheimer's disease	2.23e-05	0.000217	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—CHAT—Alzheimer's disease	2.22e-05	0.000215	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—TPI1—Alzheimer's disease	2.22e-05	0.000215	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CCR5—Alzheimer's disease	2.19e-05	0.000213	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—LPL—Alzheimer's disease	2.17e-05	0.000211	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CRH—Alzheimer's disease	2.17e-05	0.00021	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—MEF2C—Alzheimer's disease	2.15e-05	0.000209	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	2.15e-05	0.000209	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—HTR2A—Alzheimer's disease	2.14e-05	0.000208	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—TP53—Alzheimer's disease	2.13e-05	0.000207	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—MAOB—Alzheimer's disease	2.13e-05	0.000206	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—PRKCG—Alzheimer's disease	2.11e-05	0.000205	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CDK5—Alzheimer's disease	2.1e-05	0.000204	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—NGF—Alzheimer's disease	2.06e-05	0.0002	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—NPS—Alzheimer's disease	2.05e-05	0.000199	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—GAPDH—Alzheimer's disease	2.05e-05	0.000199	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PPP3CA—Alzheimer's disease	2.04e-05	0.000198	CbGpPWpGaD
Danazol—ESR1—Gene Expression—EIF2S1—Alzheimer's disease	2.03e-05	0.000197	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	2.02e-05	0.000196	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—HTR6—Alzheimer's disease	2.02e-05	0.000196	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PTK2B—Alzheimer's disease	2.02e-05	0.000196	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—AKT1—Alzheimer's disease	2.01e-05	0.000195	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	2.01e-05	0.000195	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	2e-05	0.000195	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CCR5—Alzheimer's disease	2e-05	0.000194	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CALM1—Alzheimer's disease	2e-05	0.000194	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—APOE—Alzheimer's disease	1.99e-05	0.000193	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—LEP—Alzheimer's disease	1.99e-05	0.000193	CbGpPWpGaD
Danazol—ESR1—Generic Transcription Pathway—NOTCH1—Alzheimer's disease	1.99e-05	0.000193	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—A2M—Alzheimer's disease	1.98e-05	0.000192	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CAV1—Alzheimer's disease	1.97e-05	0.000192	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—GAB2—Alzheimer's disease	1.96e-05	0.00019	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—SST—Alzheimer's disease	1.96e-05	0.00019	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—HTR2A—Alzheimer's disease	1.96e-05	0.00019	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—NTRK2—Alzheimer's disease	1.96e-05	0.00019	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—IL6—Alzheimer's disease	1.94e-05	0.000189	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—GSK3A—Alzheimer's disease	1.94e-05	0.000189	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	1.94e-05	0.000188	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—APP—Alzheimer's disease	1.91e-05	0.000185	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—ESR1—Alzheimer's disease	1.9e-05	0.000185	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—F2—Alzheimer's disease	1.88e-05	0.000182	CbGpPWpGaD
Danazol—ESR1—Generic Transcription Pathway—PPARG—Alzheimer's disease	1.88e-05	0.000182	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—NOTCH1—Alzheimer's disease	1.84e-05	0.000178	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PSENEN—Alzheimer's disease	1.84e-05	0.000178	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CALM1—Alzheimer's disease	1.83e-05	0.000177	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—LEP—Alzheimer's disease	1.82e-05	0.000177	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—APOE—Alzheimer's disease	1.82e-05	0.000177	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—APH1A—Alzheimer's disease	1.81e-05	0.000176	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CAV1—Alzheimer's disease	1.81e-05	0.000175	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—AKT1—Alzheimer's disease	1.8e-05	0.000175	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PLCB1—Alzheimer's disease	1.8e-05	0.000175	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—AKT1—Alzheimer's disease	1.79e-05	0.000174	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	1.77e-05	0.000172	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	1.76e-05	0.000171	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—NCSTN—Alzheimer's disease	1.76e-05	0.000171	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—ESR1—Alzheimer's disease	1.74e-05	0.000169	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—GSK3B—Alzheimer's disease	1.73e-05	0.000167	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—ACHE—Alzheimer's disease	1.72e-05	0.000167	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—LRP1—Alzheimer's disease	1.72e-05	0.000167	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—F2—Alzheimer's disease	1.72e-05	0.000167	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CREB1—Alzheimer's disease	1.71e-05	0.000166	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—INS—Alzheimer's disease	1.7e-05	0.000165	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—INPP5D—Alzheimer's disease	1.7e-05	0.000165	CbGpPWpGaD
Danazol—PGR—Gene Expression—ESR1—Alzheimer's disease	1.69e-05	0.000164	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—NGFR—Alzheimer's disease	1.68e-05	0.000163	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—NOTCH1—Alzheimer's disease	1.68e-05	0.000163	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—GAL—Alzheimer's disease	1.68e-05	0.000163	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—GFAP—Alzheimer's disease	1.68e-05	0.000163	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—IGF1—Alzheimer's disease	1.65e-05	0.00016	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—ADAM10—Alzheimer's disease	1.64e-05	0.000159	CbGpPWpGaD
Danazol—PGR—Gene Expression—NOTCH1—Alzheimer's disease	1.63e-05	0.000158	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—ENO1—Alzheimer's disease	1.61e-05	0.000156	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PTGS1—Alzheimer's disease	1.61e-05	0.000156	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—CYP2D6—Alzheimer's disease	1.58e-05	0.000153	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—GSK3B—Alzheimer's disease	1.58e-05	0.000153	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CREB1—Alzheimer's disease	1.57e-05	0.000152	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	1.56e-05	0.000151	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—INS—Alzheimer's disease	1.56e-05	0.000151	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—S100B—Alzheimer's disease	1.55e-05	0.000151	CbGpPWpGaD
Danazol—PGR—Gene Expression—PPARG—Alzheimer's disease	1.54e-05	0.000149	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CCL2—Alzheimer's disease	1.53e-05	0.000149	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—IGF1—Alzheimer's disease	1.51e-05	0.000146	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—BCHE—Alzheimer's disease	1.5e-05	0.000145	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	1.49e-05	0.000145	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—NOS3—Alzheimer's disease	1.49e-05	0.000145	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—A2M—Alzheimer's disease	1.48e-05	0.000144	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—IGF2—Alzheimer's disease	1.48e-05	0.000144	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PSEN2—Alzheimer's disease	1.43e-05	0.000139	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—IGF1R—Alzheimer's disease	1.43e-05	0.000139	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PLCB1—Alzheimer's disease	1.41e-05	0.000137	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	1.39e-05	0.000135	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—LPL—Alzheimer's disease	1.37e-05	0.000133	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—ABCA1—Alzheimer's disease	1.37e-05	0.000133	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—NOS3—Alzheimer's disease	1.37e-05	0.000132	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MEF2C—Alzheimer's disease	1.36e-05	0.000132	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PRKCG—Alzheimer's disease	1.33e-05	0.000129	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CA4—Alzheimer's disease	1.33e-05	0.000129	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—NPY—Alzheimer's disease	1.32e-05	0.000128	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IAPP—Alzheimer's disease	1.31e-05	0.000127	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—NGF—Alzheimer's disease	1.3e-05	0.000126	CbGpPWpGaD
Danazol—AR—Gene Expression—ESR1—Alzheimer's disease	1.29e-05	0.000125	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CRH—Alzheimer's disease	1.27e-05	0.000123	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CASP3—Alzheimer's disease	1.27e-05	0.000123	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CCR5—Alzheimer's disease	1.26e-05	0.000123	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—IL6—Alzheimer's disease	1.26e-05	0.000122	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	1.25e-05	0.000121	CbGpPWpGaD
Danazol—AR—Gene Expression—NOTCH1—Alzheimer's disease	1.24e-05	0.000121	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—HTR2A—Alzheimer's disease	1.24e-05	0.00012	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—NPS—Alzheimer's disease	1.21e-05	0.000117	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PPP3CA—Alzheimer's disease	1.2e-05	0.000116	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PTK2B—Alzheimer's disease	1.18e-05	0.000115	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	1.18e-05	0.000115	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PPARGC1A—Alzheimer's disease	1.18e-05	0.000115	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—HMOX1—Alzheimer's disease	1.18e-05	0.000114	CbGpPWpGaD
Danazol—AR—Gene Expression—PPARG—Alzheimer's disease	1.17e-05	0.000114	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—AKT1—Alzheimer's disease	1.17e-05	0.000114	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—MAPK8—Alzheimer's disease	1.16e-05	0.000113	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—AKT1—Alzheimer's disease	1.16e-05	0.000113	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CASP3—Alzheimer's disease	1.16e-05	0.000112	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CALM1—Alzheimer's disease	1.15e-05	0.000112	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—IL6—Alzheimer's disease	1.15e-05	0.000112	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—GAB2—Alzheimer's disease	1.15e-05	0.000112	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—SST—Alzheimer's disease	1.15e-05	0.000112	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—NTRK2—Alzheimer's disease	1.15e-05	0.000112	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—LEP—Alzheimer's disease	1.15e-05	0.000112	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—APOE—Alzheimer's disease	1.15e-05	0.000112	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—GSK3A—Alzheimer's disease	1.14e-05	0.000111	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CAV1—Alzheimer's disease	1.14e-05	0.00011	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PLD3—Alzheimer's disease	1.13e-05	0.000109	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—APP—Alzheimer's disease	1.12e-05	0.000109	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—ESR1—Alzheimer's disease	1.1e-05	0.000106	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—F2—Alzheimer's disease	1.08e-05	0.000105	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	1.08e-05	0.000105	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—VEGFA—Alzheimer's disease	1.08e-05	0.000104	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—LPL—Alzheimer's disease	1.07e-05	0.000104	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—MAPK8—Alzheimer's disease	1.07e-05	0.000103	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—AKT1—Alzheimer's disease	1.06e-05	0.000103	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—NOTCH1—Alzheimer's disease	1.06e-05	0.000103	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PLCB1—Alzheimer's disease	1.06e-05	0.000103	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	1.04e-05	0.000101	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ND1—Alzheimer's disease	1e-05	9.74e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—GSK3B—Alzheimer's disease	9.95e-06	9.66e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CREB1—Alzheimer's disease	9.87e-06	9.58e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—TGFB1—Alzheimer's disease	9.87e-06	9.58e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—NGFR—Alzheimer's disease	9.87e-06	9.58e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—VEGFA—Alzheimer's disease	9.84e-06	9.55e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—INS—Alzheimer's disease	9.82e-06	9.53e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—MTHFR—Alzheimer's disease	9.68e-06	9.39e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CCL2—Alzheimer's disease	9.66e-06	9.37e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—ADAM10—Alzheimer's disease	9.64e-06	9.36e-05	CbGpPWpGaD
Danazol—ESR1—Gene Expression—NOTCH1—Alzheimer's disease	9.57e-06	9.29e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—IGF1—Alzheimer's disease	9.5e-06	9.22e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—S100B—Alzheimer's disease	9.12e-06	8.85e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—CALM1—Alzheimer's disease	9.04e-06	8.77e-05	CbGpPWpGaD
Danazol—ESR1—Gene Expression—PPARG—Alzheimer's disease	9.04e-06	8.77e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—TGFB1—Alzheimer's disease	9.03e-06	8.76e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—APOE—Alzheimer's disease	9.01e-06	8.74e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—CAV1—Alzheimer's disease	8.93e-06	8.66e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IGF2—Alzheimer's disease	8.68e-06	8.42e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—NOS3—Alzheimer's disease	8.61e-06	8.36e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IGF1R—Alzheimer's disease	8.39e-06	8.15e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—TP53—Alzheimer's disease	8.13e-06	7.89e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—LPL—Alzheimer's disease	8.05e-06	7.81e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MEF2C—Alzheimer's disease	7.97e-06	7.74e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PPARG—Alzheimer's disease	7.85e-06	7.62e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PRKCG—Alzheimer's disease	7.82e-06	7.59e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—INS—Alzheimer's disease	7.7e-06	7.47e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—NGF—Alzheimer's disease	7.62e-06	7.4e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—IL6—Alzheimer's disease	7.44e-06	7.22e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—TP53—Alzheimer's disease	7.43e-06	7.21e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CCR5—Alzheimer's disease	7.41e-06	7.19e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CASP3—Alzheimer's disease	7.31e-06	7.09e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—HTR2A—Alzheimer's disease	7.26e-06	7.04e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—AKT1—Alzheimer's disease	6.86e-06	6.66e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—IL6—Alzheimer's disease	6.8e-06	6.6e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CALM1—Alzheimer's disease	6.77e-06	6.57e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—NOS3—Alzheimer's disease	6.75e-06	6.55e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—LEP—Alzheimer's disease	6.75e-06	6.55e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—APOE—Alzheimer's disease	6.75e-06	6.55e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MAPK8—Alzheimer's disease	6.72e-06	6.52e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CAV1—Alzheimer's disease	6.68e-06	6.49e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—TPI1—Alzheimer's disease	6.47e-06	6.28e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CHAT—Alzheimer's disease	6.47e-06	6.28e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—F2—Alzheimer's disease	6.36e-06	6.17e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—AKT1—Alzheimer's disease	6.28e-06	6.09e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—NOTCH1—Alzheimer's disease	6.22e-06	6.04e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—MAOB—Alzheimer's disease	6.2e-06	6.02e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—VEGFA—Alzheimer's disease	6.2e-06	6.02e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PTGS2—Alzheimer's disease	6.17e-06	5.99e-05	CbGpPWpGaD
Danazol—PGR—Gene Expression—AKT1—Alzheimer's disease	6.09e-06	5.91e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	5.97e-06	5.8e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—GSK3B—Alzheimer's disease	5.84e-06	5.67e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CREB1—Alzheimer's disease	5.79e-06	5.62e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—A2M—Alzheimer's disease	5.77e-06	5.6e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—INS—Alzheimer's disease	5.76e-06	5.59e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—TGFB1—Alzheimer's disease	5.69e-06	5.52e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CCL2—Alzheimer's disease	5.67e-06	5.5e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IGF1—Alzheimer's disease	5.57e-06	5.41e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—NOS3—Alzheimer's disease	5.05e-06	4.9e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ACHE—Alzheimer's disease	5.02e-06	4.87e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	4.96e-06	4.81e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	4.7e-06	4.56e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ENO1—Alzheimer's disease	4.7e-06	4.56e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—TP53—Alzheimer's disease	4.69e-06	4.55e-05	CbGpPWpGaD
Danazol—AR—Gene Expression—AKT1—Alzheimer's disease	4.64e-06	4.5e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	4.61e-06	4.47e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—BCHE—Alzheimer's disease	4.37e-06	4.24e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CASP3—Alzheimer's disease	4.29e-06	4.16e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—IL6—Alzheimer's disease	4.29e-06	4.16e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	4.12e-06	4e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	4e-06	3.88e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—AKT1—Alzheimer's disease	3.96e-06	3.84e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MAPK8—Alzheimer's disease	3.94e-06	3.83e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—VEGFA—Alzheimer's disease	3.64e-06	3.53e-05	CbGpPWpGaD
Danazol—ESR1—Gene Expression—AKT1—Alzheimer's disease	3.57e-06	3.47e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	3.45e-06	3.34e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	3.43e-06	3.33e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TGFB1—Alzheimer's disease	3.34e-06	3.24e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—LPL—Alzheimer's disease	3.14e-06	3.04e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—AKT1—Alzheimer's disease	3.1e-06	3.01e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	2.82e-06	2.74e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TP53—Alzheimer's disease	2.75e-06	2.67e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CALM1—Alzheimer's disease	2.64e-06	2.56e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—APOE—Alzheimer's disease	2.63e-06	2.55e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CAV1—Alzheimer's disease	2.61e-06	2.53e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IL6—Alzheimer's disease	2.52e-06	2.44e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—AKT1—Alzheimer's disease	2.32e-06	2.25e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PPARG—Alzheimer's disease	2.29e-06	2.22e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—INS—Alzheimer's disease	2.25e-06	2.18e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—NOS3—Alzheimer's disease	1.97e-06	1.91e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	1.8e-06	1.75e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—AKT1—Alzheimer's disease	9.06e-07	8.79e-06	CbGpPWpGaD
